Formulation and Evaluation of Orodispersible Tablet Containing Combination of Phosphodiesterase-5 Inhibitor and Herbal Aphrodisiac. Int J Ayu Pharm Res 2023, 11 (2), 13-30. https://doi.org/10.47070/ijapr.v11i2.2700.